The Times Australia
The Times World News

.
The Times Real Estate

.

Two years into the pandemic, why is Australia still short of medicines?

  • Written by Maryam Ziaee, Lecturer and Researcher, Supply Chains and Operations, Victoria University
Two years into the pandemic, why is Australia still short of medicines?

This might be a familiar scene. You pop into your local pharmacy to fill a script and you’re told your regular medicine is out of stock. When will it be in? Sorry, we don’t have a date. But I’ll ring up your GP to see if she can authorise an alternative.

This is a common conversation more than two years into the pandemic. So why, when our borders are open and planes are arriving from overseas with medicines on board, do we still have medicine shortages?

This may be surprising, but medicine shortages have been an ongoing issue in Australia. The pandemic only made it more visible.

For my PhD research[1], I looked at Australia’s pharmaceutical supply chain – the process of how medicines get from manufacturers to wholesalers and then to pharmacies.

I interviewed 20 supply-chain experts from 15 Australian and multinational companies. Here’s what I found, and what we could be doing better.

Read more: I've heard COVID is leading to medicine shortages. What can I do if my medicine is out of stock?[2]

If it’s not the pandemic, what’s going on?

The Therapeutic Goods Administration database[3] lists shortages of 263 medicines, with a critical shortage of 27 of them. Shortages of 65 more medicines are expected. The list is updated daily.

However, the pandemic is not the root cause of medicine shortages. So border openings will not solve the problem.

Even before the pandemic, we were regularly seeing medicine shortages[4] at similar levels.

The pharmaceutical industry is fundamentally different from other industries. Developing medicines is an extremely lengthy process, with no guarantee of success. Some 90% of candidate drugs don’t complete clinical trials[5]. Of those that do, not all make it to market[6].

Some drugs are also “personalised[7]” so they are better targeted to an individual patient’s needs. This means small quantities of tailored drugs may be needed.

So organisations, such as drug manufacturers, wholesalers and hospitals, mainly rely on historical data to plan the production and distribution of medicines.

Blister packs of green capsules being made in a factory
Until now, it’s been hard to predict which medicines need to be made and distributed to meet demand. Shutterstock[8]

However, Australia’s pharmaceutical supply chain is highly fragmented[9]. There’s little coordination or data sharing among manufacturers, wholesalers and pharmacies. This leads to poor communication and incomplete or inaccurate information.

For instance, manufacturers may have little or no access to pharmacy data and stock levels. So, they cannot adequately plan for medicine production, which can take from several months to a year.

Australia also accounts for only 2% of the world’s drug market[10], a small one for multinational pharmaceutical manufacturers. So their domestic suppliers generally keep a low stock due to short expiry dates and profit margins.

The slightest disruption, such as disease outbreaks or natural disasters, can easily spike demands and cause a shortage. Pandemic-related supply chain disruptions only make the existing challenges worse.

Read more: Supermarket shortages are different this time: how to respond and avoid panic[11]

What can we do about it?

If a medicine is in short supply, there may be an alternative option a doctor can prescribe. But substituting medicines can lead to[12] side effects, longer recovery times, longer stays in hospitals, and increased health-care costs.

Some pharmacies and wholesalers overstock their warehouses if they anticipate a shortage. But that is costly and medicines might expire before they are used. These are only short-term solutions.

So we need a system-wide and nationally coordinated approach among supply chain partners and the government to reduce the risk of medicine shortages.

Looking at vast amounts of data, from many sources, in real time is the key. Shutterstock

We could do this using artificial intelligence technologies such as “big data analytics[13]” and sharing data across the pharmaceutical supply chain.

Big data analytics can store and analyse a large array of data in different formats, from different sources, in real time. This would create an integrated database for all pharmaceutical supply-chain partners to have access to. This would allow all partners to monitor and predict demand in real time.

For example, a pharmacist would be able to access a centralised database on their computer and check the current stock level and availability of a medicine in other pharmacies, or even manufacturers and distributors. This could even help predict medicine shortages way before they occur.

For this to work, Australian pharmaceutical organisations need both robust IT and a skilled workforce that knows how to analyse and use the data. While this might be practical and affordable for pharmaceutical companies, this might not be the case for hospital or community pharmacies.

So governments would need to support[14] pharmacies and other smaller players – technically, financially, and with appropriate policies and regulations – to make sure they could access and use the data.

We need to plan for the next crisis

The current pandemic may be adding additional stresses to an already stretched supply chain. But future pandemics and natural disasters, such as floods and bushfires, will also worsen medicine shortages.

So we need to start planning now to create a resilient pharmaceutical supply chain that predicts medicine shortages and responds quickly.

References

  1. ^ PhD research (vuir.vu.edu.au)
  2. ^ I've heard COVID is leading to medicine shortages. What can I do if my medicine is out of stock? (theconversation.com)
  3. ^ Therapeutic Goods Administration database (apps.tga.gov.au)
  4. ^ medicine shortages (pubmed.ncbi.nlm.nih.gov)
  5. ^ don’t complete clinical trials (www.nature.com)
  6. ^ not all make it to market (pubmed.ncbi.nlm.nih.gov)
  7. ^ personalised (www.sciencedirect.com)
  8. ^ Shutterstock (www.shutterstock.com)
  9. ^ fragmented (pubmed.ncbi.nlm.nih.gov)
  10. ^ 2% of the world’s drug market (www.ncbi.nlm.nih.gov)
  11. ^ Supermarket shortages are different this time: how to respond and avoid panic (theconversation.com)
  12. ^ can lead to (journals.plos.org)
  13. ^ big data analytics (www.sciencedirect.com)
  14. ^ need to support (www.pc.gov.au)

Read more https://theconversation.com/two-years-into-the-pandemic-why-is-australia-still-short-of-medicines-178608

The Times Features

Trusted Healthcare Construction Company for Modern Facilities

Achieving quality, safety, and innovative medical facilities is challenging in an ever-changing healthcare world without collaboration with a trusted healthcare construction comp...

How to Treat Hair Loss Without a Hair Transplant

Understanding Hair Loss Hair loss can significantly affect individuals, both physically and emotionally. Identifying the causes and types can help address the issue more effecti...

How to Find a Trustworthy Professional for Your Plumbing Needs

Nowra is an idyllic locality often referred to as the city of the Shoalhaven City Council in the South Coast region of New South Wales, Australia. This picturesque suburb feature...

How to Choose a Mattress for Back/Neck Pain and All Sleepers?

Waking up with a stiff neck or aching back can derail your entire day. If you're one of the millions struggling with chronic pain, a supportive mattress is more than a luxury – i...

What to Look for in a Professional Debt Collection Service

Often in life, overdue payments are accidental or caused by unusual circumstances. This can cause some temporary convenience, but everything carries on as usual. However, when th...

Be inspired by celeb home decor from across the globe

GET THE LOOK: INDULGE IN THE SAME INTERIOR AS YOUR FAVE CELEBS There is a reason that Denmark ranks the highest on the happiness scale worldwide, one word: Hygge. Hygge. Hygge is ...

Times Magazine

The Essential Guide to Transforming Office Spaces for Maximum Efficiency

Why Office Fitouts MatterA well-designed office can make all the difference in productivity, employee satisfaction, and client impressions. Businesses of all sizes are investing in updated office spaces to create environments that foster collaborat...

The A/B Testing Revolution: How AI Optimized Landing Pages Without Human Input

A/B testing was always integral to the web-based marketing world. Was there a button that converted better? Marketing could pit one against the other and see which option worked better. This was always through human observation, and over time, as d...

Using Countdown Timers in Email: Do They Really Increase Conversions?

In a world that's always on, where marketers are attempting to entice a subscriber and get them to convert on the same screen with one email, the power of urgency is sometimes the essential element needed. One of the most popular ways to create urg...

Types of Software Consultants

In today's technology-driven world, businesses often seek the expertise of software consultants to navigate complex software needs. There are several types of software consultants, including solution architects, project managers, and user experienc...

CWU Assistive Tech Hub is Changing Lives: Win a Free Rollator Walker This Easter!

🌟 Mobility. Independence. Community. All in One. This Easter, the CWU Assistive Tech Hub is pleased to support the Banyule community by giving away a rollator walker. The giveaway will take place during the Macleod Village Easter Egg Hunt & Ma...

"Eternal Nurture" by Cara Barilla: A Timeless Collection of Wisdom and Healing

Renowned Sydney-born author and educator Cara Barilla has released her latest book, Eternal Nurture, a profound collection of inspirational quotes designed to support mindfulness, emotional healing, and personal growth. With a deep commitment to ...

LayBy Shopping